177Ga-PSMA-617/Pluvicto

177Ga-PSMA-617/Pluvicto is an emerging radiopharmaceutical used for targeted radioactive therapy of cancer.PSMA-617 is a small molecule that selectively binds to prostate-specific membrane antigen (PSMA), a protein highly expressed on prostate cancer cells. By combining this targeting molecule with Gallium-177, which emits beta particles, it is possible to deliver targeted radiation to prostate cancer cells.

Virtual price, please inquire if needed.

We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.

msds of 177Ga-PSMA-617 Pluvicto